Univercells Technologies and VectorBuilder Partner for Custom Viral Vector Production

Univercells Technologies, a provider of novel biomanufacturing technologies for flexible and scalable viral vector production, has formed a partnership with VectorBuilder, a vector design, optimization and manufacturing company. Univercells Technologies will work with VectorBuilder’s manufacturing center in Guangzhou, China to develop and optimize platform processes using best-in-class technologies for the production of custom viral vectors for cell and gene therapies as well as vaccine applications.

With rapid advances in cell and gene therapy in recent years as well as intensified interests in recombinant viral vaccines brought on by COVID-19, the demand for custom viral vectors has significantly increased.. With this partnership, both companies aim to combine and develop a portfolio of optimized viral vector manufacturing protocols.

“We are extremely pleased to partner with Univercells Technologies to co-develop optimized, scalable and customizable solutions for fast and affordable production of viral vectors.”, says Dr. Jason Ye, Vice President of Biomanufacturing of VectorBuilder.

Both the scale-X bioreactor portfolio and the NevoLine Upstream platform offer high-performing production capacities while drastically reducing footprint and costs. The scale-X hydro (2.4 m2) and carbo (10 and 30 m2) bioreactors are a great asset for accelerating process development and supporting clinical validation. Complemented by the NevoLine™ Upstream platform with integrated scale-X nitro (200 and 600 m2) bioreactor the comprehensive technology range offered by Univercells Technologies enables a seamless transition to commercial manufacture.

The scale-X hydro and carbo systems and the NevoLine Upstream platform are employed for process optimization in VectorBuilder's state-of-the-art GMP Process Development facility in Guangzhou, China for intensified and continuous vector manufacturing at commercial scale.

Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from Pharmaceutical Outsourcing – all delivered right to your inbox!
Sign up now!

  • <<
  • >>

Join the Discussion